HUP9904485A2 - Lowering blood levels of lipoprotein (a) - Google Patents

Lowering blood levels of lipoprotein (a)

Info

Publication number
HUP9904485A2
HUP9904485A2 HU9904485A HUP9904485A HUP9904485A2 HU P9904485 A2 HUP9904485 A2 HU P9904485A2 HU 9904485 A HU9904485 A HU 9904485A HU P9904485 A HUP9904485 A HU P9904485A HU P9904485 A2 HUP9904485 A2 HU P9904485A2
Authority
HU
Hungary
Prior art keywords
lipoprotein
blood levels
lowering blood
blood level
procedures
Prior art date
Application number
HU9904485A
Other languages
Hungarian (hu)
Inventor
George Chang
Ernest S. Hamanaka
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of HU9904485D0 publication Critical patent/HU9904485D0/en
Publication of HUP9904485A2 publication Critical patent/HUP9904485A2/en
Publication of HUP9904485A3 publication Critical patent/HUP9904485A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány emlősök lipőprőtein(A) vérszintjének csökkentéséreszőlgáló eljárásőkra vőnatkőzik, amely eljárásők az ezt igénylőemlősbe, a lipőprőtein A vérszintjének csökkentésére, hatékőnymennyiségű apőlipőprőtein B szekréciós gátló/mikrőszómális trigliceridtranszfer fehérje inhibitőr beadást tartalmazzák. ŕThe invention relates to procedures for reducing the blood level of lipoprotein (A) in mammals, which procedures include the administration of an effective amount of lipoprotein B secretion inhibitor/microsomal triglyceride transfer protein inhibitor to the mammal in need, to reduce the blood level of lipoprotein A. ŕ

HU9904485A 1998-12-04 1999-12-03 Lowering blood levels of lipoprotein (a) HUP9904485A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11110098P 1998-12-04 1998-12-04

Publications (3)

Publication Number Publication Date
HU9904485D0 HU9904485D0 (en) 2000-02-28
HUP9904485A2 true HUP9904485A2 (en) 2000-08-28
HUP9904485A3 HUP9904485A3 (en) 2000-09-28

Family

ID=22336605

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904485A HUP9904485A3 (en) 1998-12-04 1999-12-03 Lowering blood levels of lipoprotein (a)

Country Status (6)

Country Link
JP (1) JP2000169395A (en)
KR (1) KR20000047857A (en)
CA (1) CA2291471A1 (en)
HU (1) HUP9904485A3 (en)
IL (1) IL133201A0 (en)
ZA (1) ZA997446B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324801A1 (en) * 1999-11-10 2001-05-10 Andrew Gordon Swick Use of apo b secretion/mtp inhibitors and anti-obesity agents
IL139450A0 (en) * 1999-11-10 2001-11-25 Pfizer Prod Inc Methods of administering apo b-secretion/mtp inhibitors
IL139449A0 (en) * 1999-11-10 2001-11-25 Pfizer Prod Inc Use of apo b secretion/mtp inhibitors
CA2324800A1 (en) * 1999-11-10 2001-05-10 Mary Anne Hickman Use of apo b secretion/mtp inhibitors
SG165154A1 (en) 2002-02-28 2010-10-28 Japan Tobacco Inc Ester compound and medical use thereof
EP1669345A4 (en) 2003-08-29 2008-02-20 Japan Tobacco Inc Ester derivative and medicinal use thereof
JP5697296B2 (en) 2004-03-05 2015-04-08 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Method for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia with minimal side effects
US8101774B2 (en) 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof

Also Published As

Publication number Publication date
CA2291471A1 (en) 2000-06-04
HU9904485D0 (en) 2000-02-28
ZA997446B (en) 2001-06-04
HUP9904485A3 (en) 2000-09-28
JP2000169395A (en) 2000-06-20
IL133201A0 (en) 2001-03-19
KR20000047857A (en) 2000-07-25

Similar Documents

Publication Publication Date Title
EE04916B1 (en) Imidazop rididine derivatives, which inhibit gastric acid secretion
NO20013444D0 (en) Triazole compounds with the dopamine D3 receptor affinity
BG104780A (en) Inhibitors of phospholipase enzymes
TR199800759T2 (en) Protein Kinase C Inhibitor.
DK0921785T3 (en) Combination of acid protease enzymes and acidic buffers and uses thereof
TR200000812T2 (en) 2-methyl-thieno-benzodiazepine formulation.
NO20003600L (en) Potassium channel inhibitors
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
EP0948327A4 (en) Antidiabetic agents
DE69935720D1 (en) DIAMINO-PROPANOL COMPOUNDS FOR THE TREATMENT OF ISCHEMAS
DK1468689T3 (en) 2-methyl-thieno-benzodiazepine formulation
HUP9904485A2 (en) Lowering blood levels of lipoprotein (a)
SE9802794D0 (en) New compounds
EP1099442A3 (en) Methods of administering apo B-secretion/MTP inhibitors
DE69823493D1 (en) TETRAHYDROPYRIDOVERBINDUNGEN
SE9802793D0 (en) New compounds
NO20014241D0 (en) C16-unsaturated FP-selective prostaglandin analogs
EE200300129A (en) Use of distamycin alpha-haloacryloyl derivative
DK1240313T3 (en) Enzymes that are homologous to heparanase and their splice variants
IL139144A0 (en) Mycobacterial inhibitors
FR2743948B1 (en) SHEATH, ESPECIALLY FOR HOSPITAL ESTABLISHMENT
TR199801799T2 (en) Severe aggression treatment.
DE69923017D1 (en) Vibration-isolating bearing
HU9700144D0 (en) D78oa variety of synthetical population descending sunflower line for breeding of early ripe sunflower hybrids (helianthus annuus l.)
IT1311936B1 (en) FOOT FOR FURNITURE.